| scholarly article | Q13442814 |
| P2093 | author name string | C J L M Meijer | |
| P J F Snijders | |||
| P J Lamey | |||
| P Maxwell | |||
| I van der Waal | |||
| I Cruz | |||
| C G Cowan | |||
| T A Gregg | |||
| S S Napier | |||
| J M M Walboomers | |||
| P2860 | cites work | Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. | Q53427143 |
| Proliferative verrucous leukoplakia. A long-term study of thirty patients. | Q54445352 | ||
| Leukoplakia revisited.A clinicopathologic study 3256 oral leukoplakias | Q67313979 | ||
| Oral leukoplakia and malignant transformation. A follow-up study of 257 patients | Q70788858 | ||
| Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck | Q71907676 | ||
| Oral epithelial dysplasia and the development of invasive squamous cell carcinoma | Q71915056 | ||
| p53 gene mutations as markers of tumor spread in synchronous oral cancers | Q72159810 | ||
| Can molecular assessment improve classification of head and neck premalignancy? | Q73483184 | ||
| Genetic progression and clonal relationship of recurrent premalignant head and neck lesions | Q73483193 | ||
| Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease | Q73634279 | ||
| A high prevalence of p53 mutations in pre-malignant oral erythroplakia | Q77959337 | ||
| [Leukoplakia of the oral cavity and precancerous conditions.] | Q80743976 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| Cancer. p53, guardian of the genome | Q29615610 | ||
| Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. | Q30841779 | ||
| Genetic progression model for head and neck cancer: implications for field cancerization | Q34382909 | ||
| Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation | Q34587260 | ||
| Advanced methods in the evaluation of premalignant lesions and carcinomas of the oral mucosa | Q38154323 | ||
| A low incidence of p53 mutations in pre-malignant lesions of the oral cavity from non-tobacco users | Q38481351 | ||
| p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma | Q39116190 | ||
| p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management | Q39119715 | ||
| Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis | Q40694250 | ||
| Predicting cancer development in oral leukoplakia: ten years of translational research | Q40764826 | ||
| Management of potentially malignant oral mucosal lesions by consultant UK oral and maxillofacial surgeons. | Q40951730 | ||
| Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions | Q41007002 | ||
| Proliferative verrucous leukoplakia: a follow-up study of 54 cases | Q41575467 | ||
| Oral leukoplakia: a clinicopathological review | Q41671855 | ||
| Oral leukoplakias: to treat or not? | Q41671874 | ||
| p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma | Q42519547 | ||
| High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay | Q43601202 | ||
| p53 immunostaining of surgical margins as a predictor of local recurrence in squamous cell carcinoma of the oral cavity and oropharynx | Q44741391 | ||
| Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. | Q50635940 | ||
| Leukoplakia: still a gallimaufry or is progress being made?--A review. | Q51092797 | ||
| Observer variability in the histologic assessment of oral premalignant lesions. | Q52877568 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 98-104 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Journal of Clinical Pathology | Q6294965 |
| P1476 | title | Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland | |
| P478 | volume | 55 |
| Q37903910 | An overview of the molecular pathology of head and neck cancer, and its clinical implications. |
| Q42471453 | Assessment of p63 expression in oral squamous cell carcinomas and dysplasias |
| Q38157868 | Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia? |
| Q53269834 | Coexpression of p53 and Ki 67 and lack of c-erbB2 expression in oral leukoplakias in India. |
| Q42198695 | Correlation between expressions of Cyclin-D1, EGFR and p53 with chemoradiation response in patients of locally advanced oral squamous cell carcinoma |
| Q37050708 | Elevated Preoperative Serum Alanine Aminotransferase/Aspartate Aminotransferase (ALT/AST) Ratio Is Associated with Better Prognosis in Patients Undergoing Curative Treatment for Gastric Adenocarcinoma |
| Q42463333 | Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma |
| Q42436828 | From laryngeal epithelial precursor lesions to squamous carcinoma of the larynx: the role of cell cycle proteins and β-catenin |
| Q44464539 | Genetic and protein markers related to laryngeal epithelial precursor lesions and their neoplastic progression |
| Q41052677 | Identification of a combined biomarker for malignant transformation in oral submucous fibrosis |
| Q36213310 | Impact of EGFR and p53 expressions on survival and quality of life in locally advanced oral squamous cell carcinoma patients treated with chemoradiation |
| Q34810915 | Impact of genomic instability in risk assessment and chemoprevention of oral premalignancies |
| Q39861412 | Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma. |
| Q36738070 | Molecular genetics of premalignant oral lesions |
| Q83242624 | Oral dysplasia: biomarkers, treatment, and follow-up |
| Q53291457 | Oral leukoplakias with different degrees of dysplasia: comparative study of hMLH1, p53, and AgNOR. |
| Q41978143 | Predictive Role of p53 Protein as a Single Marker or Associated to Ki67 Antigen in Oral Carcinogenesis |
| Q35056158 | Predictive Role of p53 Protein as a Single Marker or Associated with ki67 Antigen in Oral Leukoplakia: A Retrospective Longitudinal Study. |
| Q42539816 | Proliferation and apoptosis markers in oral submucous fibrosis |
| Q41838045 | Regulation of p53 during senescence in normal human keratinocytes. |
| Q47716462 | Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients |
| Q35586451 | Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomas |
| Q42355178 | Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation |
| Q34326109 | Urban legends series: oral leukoplakia. |
| Q42498646 | p53 and ki67 as biomarkers in determining response to chemoprevention for oral leukoplakia. |
| Q53347345 | p57(kip2) expression is related to carcinogenesis and tumor progression in laryngeal tissues. |
Search more.